|
|
Drug-induced nonimmune thrombocytopenia |
| Definition: |
|
Drug-induced nonimmune thrombocytopenia is a reduction in normally functioning platelets that can be caused by certain drugs. Bleeding can be life-threatening if it occurs in the brain or other vital organ. Other drugs can increase the risk of bleeding by preventing platelets from working normally. A common example of this is aspirin. |
| Alternative Names: |
| Thrombocytopenia (nonimmune) drug-induced; Nonimmune thrombocytopenia - drug-induced |
Reviewed By: William Matsui, M.D., Department of Oncology, Johns Hopkins Hospital, Baltimore, MD. Review provided by VeriMed Healthcare Network.
 |
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
